CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
421-435 of 1027
Stephen Liu, MD
Joshua K. Sabari, MD
Susan Scott, MD
Finding the Optimal Treatment for EGFR-mutated Metastatic NSCLC
MinuteCE®Finding the Optimal Treatment for EGFR-mutated Metastatic NSCLC
Stephen Liu, MD
Joshua K. Sabari, MD
Susan Scott, MD
Clinical Data Prompting Guideline Updates for Subcutaneous ICIs in Melanoma
MinuteCE®Clinical Data Prompting Guideline Updates for Subcutaneous ICIs in Melanoma
Hussein Tawbi, MD, PhD
Sapna Patel, MD
Stephen Liu, MD
Joshua K. Sabari, MD
Susan Scott, MD
Updates in Limited-Stage Small Cell Lung Cancer (LS-SCLC)
MinuteCE®Updates in Limited-Stage Small Cell Lung Cancer (LS-SCLC)
Stephen Liu, MD
Joshua K. Sabari, MD
Susan Scott, MD
Addressing CKM Mortality & Morbidity in Patients With CKD and T2D: The Role of Combined ns-MRA & SGLT2i Therapy
CME/CEAddressing CKM Mortality & Morbidity in Patients With CKD and T2D: The Role of Combined ns-MRA & SGLT2i Therapy
Rajiv Agarwal, MBBS, MD, FASN, BRCU
Amy Mottl, MD, MPH
Muthiah Vaduganathan, MD, MPH
- advertisement
ADCs Across the Spectrum of HER2 Expression in Metastatic Breast Cancer
CME/CEADCs Across the Spectrum of HER2 Expression in Metastatic Breast Cancer
Reshma L. Mahtani, DO
Managing Adverse Events Associated With Menin Inhibitors
MinuteCE®Managing Adverse Events Associated With Menin Inhibitors
Ghayas Issa, MD
Amir Fathi, MD
Ghayas Issa, MD
Amir Fathi, MD
Ghayas Issa, MD
Amir Fathi, MD
Incorporating Guideline-Recommended Targeted Therapies Into R/R AML Management
MinuteCE®Incorporating Guideline-Recommended Targeted Therapies Into R/R AML Management
Ghayas Issa, MD
Amir Fathi, MD
Emerging Directions in Menin-Directed AML Therapy
MinuteCE®Emerging Directions in Menin-Directed AML Therapy
Ghayas Issa, MD
Amir Fathi, MD
- advertisement
Menin Inhibitors: Biologic and Clinical Rationale
MinuteCE®Menin Inhibitors: Biologic and Clinical Rationale
Ghayas Issa, MD
Amir Fathi, MD
Ghayas Issa, MD
Amir Fathi, MD
Ghayas Issa, MD
Amir Fathi, MD
